Lagudas, Gracelda C.

HRN: 20-56-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2022
AMPICILLIN 1GM (VIAL)
11/01/2022
11/02/2022
IVT
2gm
Q6
PROM X 4 HRS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: